A. Jason Leverone

Affiliations

  • Chief Financial Officer at Onkure Therapeutics Inc. (OKUR), 2025-06-25
  • Chief Financial Officer at Viridian Therapeutics Inc. (VRDN), 2021-01-20
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OKUR $2.38 303 $722.41 12,906 2025-06-23 Filing
OKUR $2.67 1,844 $4,925.32 13,209 2025-04-07 Filing
OKUR $3.33 1,278 $4,252.67 15,053 2025-04-04 Filing